ES8205753A1 - Procedimiento para preparar amidas tetrapeptidas n-adamanta-nosustituidas - Google Patents

Procedimiento para preparar amidas tetrapeptidas n-adamanta-nosustituidas

Info

Publication number
ES8205753A1
ES8205753A1 ES497353A ES497353A ES8205753A1 ES 8205753 A1 ES8205753 A1 ES 8205753A1 ES 497353 A ES497353 A ES 497353A ES 497353 A ES497353 A ES 497353A ES 8205753 A1 ES8205753 A1 ES 8205753A1
Authority
ES
Spain
Prior art keywords
substituted
adamantane
amino acid
acid residues
various amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES497353A
Other languages
English (en)
Other versions
ES497353A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES497353A0 publication Critical patent/ES497353A0/es
Publication of ES8205753A1 publication Critical patent/ES8205753A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR AMIDAS TETRAPEPTIDAS N-ADAMANTANOSUSTITUIDAS. CONSTA DE LAS SIGUIENTES ETAPAS: 1 TRATAR UN AMINOACIDO O PEPTIDO N-PROTEGIDO DE FORMULA A-W-X-HNCH2COOH, EN QUE A REPRESENTA UN GRUPO N-PROTECTOR, EN PRESENCIA DE UNA AMINA TERCIARIA, A TEMPERATURAS INFEIRORES A -10C, CON UN ESTER DE ACIDO CLOROFORMICO (TAL COMO EL CLOROFORMATO DE ISOBUTILO). 2 ACOPLAR EL COMPUESTO RESULTANTE CON H-Y-Z. 3 DESPROTEGER EL PRODUCTO N-BLOQUEADO RESULTANTE. SE OBTIENE EL COMPUESTO DE FORMULA GENERAL W-X-G1Y-Y-Z.
ES497353A 1979-12-03 1980-12-02 Procedimiento para preparar amidas tetrapeptidas n-adamanta-nosustituidas Expired ES8205753A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/099,765 US4273704A (en) 1979-12-03 1979-12-03 N-Adamantane-substituted tetrapeptide amides

Publications (2)

Publication Number Publication Date
ES497353A0 ES497353A0 (es) 1982-06-16
ES8205753A1 true ES8205753A1 (es) 1982-06-16

Family

ID=22276513

Family Applications (2)

Application Number Title Priority Date Filing Date
ES497353A Expired ES8205753A1 (es) 1979-12-03 1980-12-02 Procedimiento para preparar amidas tetrapeptidas n-adamanta-nosustituidas
ES508060A Expired ES8300087A1 (es) 1979-12-03 1981-12-16 Procedimiento para preparar amidas tetrapeptidas n-adamantano-sustituidas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES508060A Expired ES8300087A1 (es) 1979-12-03 1981-12-16 Procedimiento para preparar amidas tetrapeptidas n-adamantano-sustituidas.

Country Status (16)

Country Link
US (1) US4273704A (es)
JP (1) JPS5692847A (es)
AU (1) AU6499080A (es)
BE (1) BE886472A (es)
CA (1) CA1151642A (es)
DE (1) DE3044793A1 (es)
DK (1) DK513480A (es)
ES (2) ES8205753A1 (es)
FR (1) FR2476073A1 (es)
GB (1) GB2066262B (es)
IT (1) IT1127930B (es)
NL (1) NL8006586A (es)
NO (1) NO803640L (es)
PT (1) PT72141B (es)
SE (1) SE8008428L (es)
ZA (1) ZA807513B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404135A (en) * 1981-07-20 1983-09-13 G. D. Searle & Co. Enkephalin derivatives
US4407746A (en) * 1981-12-14 1983-10-04 G. D. Searle & Co. Cyclohexyl and phenyl substituted enkephalins
CS231221B1 (en) * 1982-06-29 1984-10-15 Martin Flegel L-alanyl-d-isoglutamine adamantylamide
US4629784A (en) * 1983-08-16 1986-12-16 The University Of Georgia Research Foundation, Inc. Synthesis of cyclopropane amino acids
MX7527E (es) * 1983-08-16 1989-07-25 Univ Georgia Res Found Procedimiento para la sintesis de un aminoacido de ciclopropilo
US4510085A (en) * 1984-04-12 1985-04-09 G.D. Searle & Co. Antihypertensive tetrapeptide amides
US4514332A (en) * 1984-04-16 1985-04-30 G. D. Searle & Co. Tetrapeptide adamantyl amides
FR2572399B1 (fr) * 1984-10-31 1987-01-16 Panmedica Sa Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
US4880829A (en) * 1985-08-14 1989-11-14 G. D. Searle And Company Substituted dipeptide amides #3
US4822775A (en) * 1986-02-14 1989-04-18 G. D. Searle & Co. Phenyl substituted dipeptide amides
US4758675A (en) * 1986-07-14 1988-07-19 G. D. Searle & Co. 3-thiophene-substituted tyrosyl dipeptide amides
US5652335A (en) * 1990-02-28 1997-07-29 Teikoku Seiyaku Kabushiki Kaisha Physiologically active substance well capable of permeating biomembrane
DE69130489T2 (de) * 1990-02-28 1999-05-12 Teikoku Seiyaku Kk Physiologisch aktive Substanz die fähig ist Biomembran zu permeieren
WO1998030329A1 (fr) * 1997-01-14 1998-07-16 Daicel Chemical Industries, Ltd. Catalyseurs de nitration ou de carboxylation
US7795468B2 (en) * 2001-01-19 2010-09-14 Chevron U.S.A. Inc. Functionalized higher diamondoids
US20050261302A1 (en) * 2004-04-29 2005-11-24 Hoff Ethan D Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
US20100222316A1 (en) * 2004-04-29 2010-09-02 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US7880001B2 (en) * 2004-04-29 2011-02-01 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
US20050245534A1 (en) * 2004-04-29 2005-11-03 Link James T Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
US8415354B2 (en) 2004-04-29 2013-04-09 Abbott Laboratories Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20080275112A1 (en) * 2004-07-23 2008-11-06 Schreiner Peter R Invention Concerning Aminoadamantane Compounds
CA2585735A1 (en) * 2004-11-02 2006-05-11 Pfizer Inc. Novel compounds of substituted and unsubstituted adamantyl amides
US8198331B2 (en) * 2005-01-05 2012-06-12 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20090192198A1 (en) 2005-01-05 2009-07-30 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BRPI0606256A2 (pt) 2005-01-05 2009-06-09 Abbott Lab inibidores da enzima 11-beta-hidroxiesteróide desidrogenase tipo i, uso e composição farmacêutica compreendendo os mesmos
HRP20050242B1 (en) * 2005-03-15 2010-09-30 Institut Ruđer Bošković Synthetic peptides containing unnatural adamantane related amino acids for use as antitumour drugs
JP5736098B2 (ja) 2007-08-21 2015-06-17 アッヴィ・インコーポレイテッド 中枢神経系障害を治療するための医薬組成物
EP2399926A1 (en) * 2010-06-22 2011-12-28 Justus-Liebig-Universität Giessen Peptides incorporating 3-aminoadamantane carboxylic acids enhance synaptic plasticity and act as neurogenic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732451A1 (de) * 1976-07-27 1978-02-02 Reckitt & Colmann Prod Ltd Peptidverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Also Published As

Publication number Publication date
ES497353A0 (es) 1982-06-16
AU6499080A (en) 1981-06-11
US4273704A (en) 1981-06-16
SE8008428L (sv) 1981-06-04
ZA807513B (en) 1982-07-28
NL8006586A (nl) 1981-07-01
IT1127930B (it) 1986-05-28
DE3044793A1 (de) 1981-06-19
PT72141B (en) 1981-10-28
CA1151642A (en) 1983-08-09
PT72141A (en) 1981-01-01
BE886472A (fr) 1981-06-03
JPS5692847A (en) 1981-07-27
GB2066262B (en) 1983-05-11
IT8050294A0 (it) 1980-12-02
GB2066262A (en) 1981-07-08
NO803640L (no) 1981-06-04
ES508060A0 (es) 1982-10-01
DK513480A (da) 1981-07-09
ES8300087A1 (es) 1982-10-01
FR2476073A1 (fr) 1981-08-21

Similar Documents

Publication Publication Date Title
ES8205753A1 (es) Procedimiento para preparar amidas tetrapeptidas n-adamanta-nosustituidas
DE3366428D1 (en) Dynorphin amide analogs
MY117542A (en) Kappa receptor opioid peptides
NO834340L (no) Nye polypeptider
IL205233A0 (en) A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof
ES2229045T3 (es) Derivados de peptidos terapeuticos.
PT81793A (fr) Procede de preparation de nouveaux derives peptidiques a structture polycyclique azotee
MY125555A (en) Heptapeptide oxytocin analogues
DE3689508D1 (de) Peptide.
AU531637B2 (en) Preparation of carboxylic acid amides and peptides
DE68909362T2 (de) (2R,3S,4S)-Alpha-(carboxycyclopropyl)glycin.
ES458537A1 (es) Procedimiento para preparar encefalinas 2-y-3-sustituidas.
GB2217331C (en) Oligopeptides and their use as analgesics
DE3751398D1 (de) Substrat-Peptide.
DE69227517D1 (de) Produktion von peptid-amiden
DE3267380D1 (en) Peptides and pseudopeptides in which the n terminus bears two substituents
AU8653891A (en) Amino acid analogs as cck antagonists
BG48734A1 (en) (cys above 2- sulphonamide)- methioninencephaline- amid and method for its preparation
TH8579EX (th) อนุพันธ์ของไกลซีน
ES2052447A1 (es) Peptidos hemorreguladores.